Chemoinformaics analysis of (Z)6,(Z)9-Pentadecadien-1-ol
Molecular Weight | 224.388 | nRot | 11 |
Heavy Atom Molecular Weight | 196.164 | nRig | 2 |
Exact Molecular Weight | 224.214 | nRing | 0 |
Solubility: LogS | -4.895 | nHRing | 0 |
Solubility: LogP | 5.41 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 44.5222 |
nHD | 1 | BPOL | 28.0898 |
QED | 0.401 |
Synth | 2.373 |
Natural Product Likeliness | 1.52 |
NR-PPAR-gamma | 0.386 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.312 |
HIA | 0.006 |
CACO-2 | -4.41 |
MDCK | 0.0000202 |
BBB | 0.464 |
PPB | 0.963788 |
VDSS | 2.513 |
FU | 0.0295944 |
CYP1A2-inh | 0.935 |
CYP1A2-sub | 0.183 |
CYP2c19-inh | 0.407 |
CYP2c19-sub | 0.058 |
CYP2c9-inh | 0.45 |
CYP2c9-sub | 0.916 |
CYP2d6-inh | 0.024 |
CYP2d6-sub | 0.141 |
CYP3a4-inh | 0.414 |
CYP3a4-sub | 0.058 |
CL | 9.951 |
T12 | 0.408 |
hERG | 0.03 |
Ames | 0.02 |
ROA | 0.009 |
SkinSen | 0.966 |
Carcinogencity | 0.211 |
EI | 0.976 |
Respiratory | 0.251 |
NR-Aromatase | 0.413 |
Antiviral | Yes |
Prediction | 0.786791 |